Lung Cancer Screening Software Market Projected to Show Strong Growth

Advance Market Analytics published a new research publication on "Lung Cancer Screening Software Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lung Cancer Screening Software market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/132528-global-lung-cancer-screening-software-market

Some of the key players profiled in the study are: PenRad Technologies, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Kheiron Medical Technologies (United Kingdom), Volpara Solutions Limited (New Zeland), Thynk Health (United States), CRA Health LLC (United States), ProVation Medical, Inc. (United States), Nuance Communications, Inc. (United States), Siemens Healthcare GmbH (Germany), CureMetrix, Inc. (United States).

In October 2023, DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced the initial commercial introduction of FirstLook Lung. FirstLook is a blood test that offers a convenient, accurate and personalized result by determining the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value (NPV) of 99.7 percent.

Scope of the Report of Lung Cancer Screening Software Lung cancer screening is a process used for the detection of the presence of lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening software is designed to automate the workflow of healthcare facilities by tracking patients from screening follow-up and beyond, track incidental pulmonary nodules and others.

The titled segments and sub-section of the market are illuminated below: by Enterprise (Small and Medium Enterprises, Large Enterprises), Deployment (Cloud-Based, On-Premises), Subscription (Monthly, Annual, Quarterly, Permanent)

Market Trends: Growing Awareness about Cancer Screening among People

Increased Adoption of Cloud-Based? Solutions

Opportunities: Growing Healthcare Industry Worldwide

New Advancements in the Medical Science

Market Drivers: Increased Prevalence of Lung Cancer

Increased Diagnostic Centres and Hospitals

Government Initiatives for Cancer Screening Programs Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Have Any Questions Regarding Global Lung Cancer Screening Software Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/132528-global-lung-cancer-screening-software-market

Strategic Points Covered in Table of Content of Global Lung Cancer Screening Software Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Lung Cancer Screening Software market

Chapter 2: Exclusive Summary – the basic information of the Lung Cancer Screening Software Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Lung Cancer Screening Software

Chapter 4: Presenting the Lung Cancer Screening Software Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Lung Cancer Screening Software market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source finally, Lung Cancer Screening Software Market is a valuable source of guidance for individuals and companies.

Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/132528-global-lung-cancer-screening-software-market

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact US :

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

Phone: +1 201 565 3262, +44 161 818 8166

[email protected]